Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-18
Closed -$2.31K 194
2023
Q2
$2.31K Hold
18
﹤0.01% 171
2023
Q1
$2.09K Buy
+18
New +$2.02K ﹤0.01% 179
2022
Q4
Sell
-27
Closed -$2K 169
2022
Q3
$2K Sell
27
-37
-58% -$3.13K ﹤0.01% 166
2022
Q2
$5K Buy
+64
New +$5.84K ﹤0.01% 157

Other funds holding DXCM

Rock Creek Group's DXCM Position: Q3 2023 in Review

Rock Creek Group sold out of DexCom (DXCM) in Q3 2023, closing a stake of 18 shares — an estimated $2.31K sold.

Rock Creek Group first reported a position in DXCM in Q2 2022 and held it in 4 quarters. The position peaked at $5K in Q2 2022. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Rock Creek Group reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Rock Creek Group sold 18 DexCom shares in Q3 2023, an estimated $2.31K.
  • Rock Creek Group first reported a position in DexCom in Q2 2022 and held it in 4 quarters.
  • Rock Creek Group's DexCom position peaked at $5K in Q2 2022.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Rock Creek Group's 13F filing for Q3 2023, filed 13 Nov 2023.